16042-91-4 Usage
Uses
Used in Organic Synthesis:
2-METHYL-2-MORPHOLINOPROPANAL is used as a reagent for the synthesis of amine and amide compounds, providing a convenient and efficient method for the preparation of these important organic compounds.
Used in Pharmaceutical Manufacturing:
2-METHYL-2-MORPHOLINOPROPANAL is used as a key intermediate in the production of various pharmaceutical ingredients, including anti-viral and anti-bacterial drugs. Its role in the synthesis of these therapeutic agents highlights its importance in the development of new medications.
Used in Asymmetric Synthesis:
2-METHYL-2-MORPHOLINOPROPANAL is used as a chiral auxiliary in asymmetric synthesis, enabling the selective formation of enantiomerically pure compounds. This application is crucial for the production of pharmaceuticals and other chiral molecules, where the stereochemistry of the compound can significantly impact its biological activity and safety.
Used in Chemical Research and Development:
2-METHYL-2-MORPHOLINOPROPANAL is used as a valuable chemical in the field of chemical research and development, due to its versatile applications in organic chemistry and pharmaceutical manufacturing. Its unique properties and reactivity make it an essential tool for the synthesis of novel compounds and the exploration of new chemical reactions.
Check Digit Verification of cas no
The CAS Registry Mumber 16042-91-4 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 1,6,0,4 and 2 respectively; the second part has 2 digits, 9 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 16042-91:
(7*1)+(6*6)+(5*0)+(4*4)+(3*2)+(2*9)+(1*1)=84
84 % 10 = 4
So 16042-91-4 is a valid CAS Registry Number.
InChI:InChI=1/C8H15NO2/c1-8(2,7-10)9-3-5-11-6-4-9/h7H,3-6H2,1-2H3
16042-91-4Relevant academic research and scientific papers
IMMUNOPROTEASOME INHIBITORS
-
Paragraph 0399; 0410, (2019/06/13)
Provided herein are compounds, such as a compound of Formula (I), or a pharmaceutically acceptable salt thereof, that are immunoproteasome (such as LMP2 and LMP7) inhibitors. The compounds described herein can be useful for the treatment of diseases treatable by inhibition of immunoproteasomes. Also provided herein are pharmaceutical compositions containing such compounds and processes for preparing such compounds.
IMMUNOPROTEASOME INHIBITORS
-
Paragraph 0285, (2018/08/20)
Provided herein are compounds, such as a compound of Formula (I), as described herein, or a pharmaceutically acceptable salt thereof, that are immunoproteasome (such as LMP2 and LMP7) inhibitors. The compounds described herein can be useful for the treatment of diseases treatable by inhibition of immunoproteasomes. Also provided herein are pharmaceutical compositions containing such compounds and processes for preparing such compounds.
